Nachrichten zur Abbvie Inc. Aktie

Why AbbVie Stock Topped the Market Today

A pair of convincing quarterly earnings beats -- not to mention a profitability guidance raise -- made AbbVie (NYSE: ABBV)…

AbbVies First Quarter Beat And Raise Leaves Room For More

…

AbbVie: Q1 Earnings Reinforce Positive Momentum

…

AbbVie Beats on Q1 Earnings & Sales, Raises 25 EPS View

ABBVs first-quarter earnings and sales beat estimates. The company raises its EPS guidance based on the strong sales performance of…

Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress…

AbbVie Aktie: Starkes Q1 dank Skyrizi und Rinvoq

Wien (www.aktiencheck.de) - AbbVie-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt in…

AbbVie warns of tariff exposure, U.S. policy risks while boosting forecast By Investing.com

AbbVie warns of tariff exposure, U.S. policy risks while boosting forecast…

AbbVie: Einbruch bei Humira um 51 Prozent – darum steigt die Dividenden-Aktie trotzdem

Der Pharma-Riese AbbVie muss bei seinem einstigen Top-Seller Humira kräftige Einbußen hinnehmen. Dafür glänzt das Unternehmen mit dem Wachstum bei…

AbbVie: Einbruch bei Humira um 51 Prozent – darum steigt die Dividenden-Aktie trotzdem

Der Pharma-Riese AbbVie muss bei seinem einstigen Top-Seller Humira kräftige Einbußen hinnehmen. Dafür glänzt das Unternehmen mit dem Wachstum bei…

AbbVie lifts profit forecast on strong sales of newer immunology drugs

AbbVie raised its 2025 profit forecast on Friday after strong sales of its newer immunology drugs Skyrizi and Rinvoq helped…

AbbVie lifts guidance as Q1 results top expectations

Abbvie Inc (NYSE:ABBV) shares moved higher after it reported strong results for the first quarter of 2025 and raised its full-year…

AbbVie Aktie: Zwischen Hoffnung und Skepsis

AbbVie-Aktie legt zu, doch Experten bewerten unterschiedlich. Neue Medikamente sollen Humira-Verluste ausgleichen. Bleibt die Erwartungshaltung realistisch? Analysten gespaltenAnzeigeSollten Anlege...…

Buy Stock in These Healthcare Leaders as Q1 Earnings Approach? ABBV, HCA

The medical sector can provide a defensive hedge against economic uncertainty, and investors may be eyeing AbbVie (ABBV) and HCA…

2 High-Yield Dividend Stocks to Buy for Passive Income

Passive income is essential in retirement, but building a dependable stream isnt easy. Fortunately, top-tier dividend stocks can do the…

Buy, Sell or Hold ABBV Stock? Key Tips Ahead of Q1 Earnings

Investors will likely focus on the sales performance of AbbVies blockbuster immunology drugs, Rinvoq and Skyrizi, when it reports Q1…

Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday

Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. The biotechs shares closed the day nearly 3%…

AbbVie (ABBV) Stock Moves -1.64%: What You Should Know

In the closing of the recent trading day, AbbVie (ABBV) stood at $170.16, denoting a -1.64% change from the preceding…

The Best Value ETF to Invest $500 in Right Now

Lets say you have $500 to invest and youre wondering where to park it. Thats a great position to be…

AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release

AbbVie (ABBV) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Top Research Reports for AbbVie, TJX & Charles Schwab

Todays Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), The TJX Companies, Inc. (TJX)…

The Zacks Analyst Blog Merck and AbbVie

Merck and AbbVie are included in this Analyst Blog.…

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE

NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

Investing $60,000 in These 3 Funds Could Generate Annual Income of Over $6,500

Income investors could pay attention to the price fluctuations of the assets they own. But they dont have to. What…

Under-the-radar drug stock has big rebound potential here despite turmoil, says Carter Worth

Carter breaks down the charts on large-cap pharmaceutical manufacturer AbbVie.…

The Last Time the Stock Market Started a Year This Badly Was 2022. Is Another Crash Coming?

As of Mondays close, the S&P 500 has fallen by about 15% this year (although the index regained about half…

Stocks making the biggest moves midday: Apple, Tesla, AbbVie, Delta Air Lines and more

These are the stocks posting the largest moves in midday trading.…

2 Top Dividend Stocks That Could Set You Up for Life

With equity markets in shambles due to President Donald Trumps trade policies, now might be as good a time as…

Dr. Oz Officially Confirmed as Head of the Centers for Medicare and Medicaid Services. Heres What Retirees Need to Know So Far.

From TV star to powerful government official. Thats the path taken by President Donald Trump and his new administrator of…

Is Vertex Pharmaceuticals Stock a Buy?

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex…

3 Dividend Stocks to Buy and Hold for the Next Decade

What should investors do when stocks are tanking over the short term? Probably the best answer is to think long…

2 Dividend Stocks to Buy Hand Over Fist in April

One factor that keeps some investors away from healthcare stocks is the sectors dearth of generous and reliable dividend payers.…

AbbVie (ABBV) Stock Moves -1.73%: What You Should Know

In the closing of the recent trading day, AbbVie (ABBV) stood at $201.64, denoting a -1.73% change from the preceding…

AbbVie cuts 2025 profit forecast on acquisition expenses By Reuters

AbbVie cuts 2025 profit forecast on acquisition expenses…

AbbVie cuts 2025 profit forecast on acquisition expenses

AbbVie on Thursday cut its 2025 adjusted profit forecast as the drugmaker expects to incur $248 million in acquisition-related expenses.…

3 High-Yielding Dividend Stocks That Retirees Can Buy and Forget About

"Buy and hold" is a simple strategy for investors, but it can be a hard one to stick to in…

AbbVie Stock Rises 16% Year to Date: Time to Buy, Sell or Hold?

Those who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks…

Novartis appoints Karen Hale, Chief Legal and Compliance Officer, as Klaus Moosmayer, Chief Ethics, Risk & Compliance Officer, steps down from the Executive Committee of Novartis

Basel, March 31, 2025 – Novartis announced today the appointment of Karen Hale to the expanded role of Chief Legal…

3 Relatively Safe Stocks to Buy Right Now

Investing in stocks comes with risks. Theres no way around that fact. However, some stocks can be less risky than…

5 Large Drug Stocks to Watch as Industry Recovers

R&D innovation is likely to remain a major focus area in 2025. In the Large-Cap Pharmaceuticals industry, AbbVie (ABBV), Novo…

AbbVie (ABBV) Stock Sinks As Market Gains: Heres Why

The latest trading day saw AbbVie (ABBV) settling at $209.17, representing a -0.4% change from its previous close.…

AbbVie Aktie: Erneut auf Expansionskurs!

Der Pharmakonzern diversifiziert sein Portfolio mit einem Milliarden-Deal für neuartige Gewichtsreduktionsmittel und stärkt gleichzeitig seine Position in der Onkologie. AbbVie…

Heres How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends

So, you want to invest in AbbVie (NYSE: ABBV) because its a promising dividend-paying stock, and you also want to…

S&P 500 Sell-Off: Heres Why This ETF May Be the Smartest Way to Invest in the S&P 500 Right Now

The Sun was shining brightly on the U.S. stock market over the past couple of years. Unfortunately, some clouds have…

3 Dividend Stocks to Buy for Reliable Passive Income

Youll need passive income to live well in retirement, especially with Social Securitys uncertain future. The Office of Retirement and…

AbbVie (ABBV) Stock Moves -0.29%: What You Should Know

AbbVie (ABBV) closed the most recent trading day at $213.85, moving -0.29% from the previous trading session.…

5 Reasons the Schwab U.S. Dividend Equity ETF Is a Long-Term Buy for 2030 and Beyond

Lets say you have some money in your pocket you want to invest, but youre not sure where to put…

The Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands

AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands are included in this Analyst Blog.…

1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction

Stock market sell-offs are often great opportunities to buy dividend stocks. Thats because dividend yields move in the opposite direction…

Top Analyst Reports for AbbVie, Lockheed Martin & Dell

Todays Research Daily features new research reports on 12 major stocks, including AbbVie Inc. (ABBV), Lockheed Martin Corporation (LMT) and…

S&P 500 Index Funds Yield Just 1.3%. Consider Buying These 2 Low-Cost Vanguard ETFs to Generate More Passive Income.

The heaviest weighted components of the S&P 500 are companies like Apple, Microsoft, and Nvidia -- tech leaders that tend…